ClinicalTrials.Veeva

Menu

HEPA, PM2.5, and Cardiometabolic Health

University of Southern California logo

University of Southern California

Status

Enrolling

Conditions

Cardiometabolic Health
Air Pollution

Treatments

Device: HEPA filter
Device: Sham filter

Study type

Interventional

Funder types

Other

Identifiers

NCT05718245
UL2_Study

Details and patient eligibility

About

The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.

Full description

This randomized, double-blind, crossover trial will recruit 52 non-diabetic adults and will investigate potential benefits of HEPA air purifiers on improving cardiometabolic profiles. Participants will be contacted and recruited to the study based on inclusion and exclusion criteria. After consenting, participants will be block randomized to HEPA and control groups for 6-month interventions by sex. After 6-month wash-out period, participants will be switched to the other arm of the intervention. During the trial, project specialists will complete a series of home visits before and after each intervention session to set up air purifiers and indoor and outdoor air pollution monitors, as well as conduct interview to collect questionnaire data, measure body weight and blood pressure, and collect biospecimen. In aim 1, the researcher will assess the effect of a 6-month residential HEPA intervention on changes of type 2 diabetes-related metabolic outcomes in 52 adults. In aim 2, the researchers will examine the association between reduction in indoor PM2.5 exposure brought by the intervention and changes in metabolic outcomes adjusting for ambient PM2.5 exposure. In aim 3, the researchers will explore major pathophysiologic changes pertinent to the cardio-metabolic profile of type 2 diabetes relevance in response to the intervention and changes in PM2.5 exposure.

Enrollment

52 estimated patients

Sex

All

Ages

65 to 84 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 65 and 84 years old;
  • Nonsmoker for at least 1 year;
  • History of BMI ≥ 25 kg/m2 in the past based on EMR information;
  • Either an English or Spanish speaker;
  • Live in the Los Angeles County.

Exclusion criteria

  • History of diabetes (both type 1 and type 2) or degenerative disease of the nervous system (Alzheimer's disease or dementia);
  • Currently have active cancer treatment;
  • The residential house has already had HEPA filters;
  • Participants will move out of the current house in the next 2 years;
  • Participants will spend more than one month living outside the primary home;
  • Have any health conditions that prohibit collecting health and covariate data and biospecimen;
  • The residential houses are not feasible for setting up air purifiers and air pollutants monitors;
  • Have high blood glucose from finger stick test (> 200 mg/dL).

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

52 participants in 2 patient groups

HEPA first and sham
Experimental group
Description:
This group of participants will be assigned an intervention of HEPA filters with the capacity to reduce PM2.5 levels at their residence for 6 months. After 6-month wash-out period, will be assigned to sham filters for 6 months.
Treatment:
Device: Sham filter
Device: HEPA filter
Sham first and HEPA
Sham Comparator group
Description:
This group of participants will be assigned an intervention of sham filters without the capacity to reduce PM2.5 levels at their residence for 6 months. After 6-month wash-out period, will be assigned to HEPA filters for 6 months.
Treatment:
Device: Sham filter
Device: HEPA filter

Trial contacts and locations

1

Loading...

Central trial contact

Junfeng Zhang, PhD; Zhanghua Chen, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems